Allergy Therapeutics PLC | Mutual Funds
Mutual Funds that own Allergy Therapeutics PLC
CF Odey Investment Funds - Absolute Return Fund
38,391,498
6.04%
0
1.3%
09/29/2017
Invesco Perpetual UK 2 Invt. Series - UK Strategic Income Fund
26,414,157
4.15%
-3,321,372
1.48%
03/29/2018
Marlborough UK Micro Cap Growth Fund
19,023,727
2.99%
193,331
0.41%
03/29/2018
11,671,679
1.84%
0
0.34%
06/30/2018
BlackRock UK Smaller Companies Fund
10,594,305
1.67%
0
0.55%
01/31/2018
Government Pension Fund - Global (The)
7,700,134
1.21%
-936,991
0%
12/31/2017
5,284,548
0.83%
450,000
0.75%
09/29/2017
Legal & General UK Alpha Trust
3,000,000
0.47%
0
0.5%
07/31/2018
Odey European Inc.
1,916,063
0.3%
-1,001,625
0.1%
09/29/2017
BlackRock Growth & Recovery Fund
1,419,162
0.22%
0
0.55%
01/31/2018
| Address |
Dominion Way
Worthing West Sussex BN14 8SA
United Kingdom
|
|
Employees
|
- |
| Website |
http://allergytherapeutics.com |
| Updated |
07/08/2019 |
| Allergy Therapeutics Plc is a pharmaceutical company, which focuses on the treatment and prevention of allergy with aluminum free products. It provides general information for the allergy sufferer and healthcare professionals about the prevention, diagnosis and treatment of the allergic condition with a special focus on allergy vaccination. The company was founded by Keith Iain Carter in 1998 and is headquartered in Worthing, the United Kingdom. |
